| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233403 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
A substantial proportion of patients may have moderately elevated FDG-PET SUVmax at 12 months without evidence of local failure on further follow-up. Thus, slightly elevated PET SUVmax should not be considered a surrogate for local treatment failure. Our data do not support routine serial FDG-PET/computed tomography for follow-up of patients receiving SBRT for Stage I NSCLC.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mark A. M.D., David J. M.D., James W. M.D., Pei-Fen Pharm.D., Mark M.D., Constantin T. Ph.D., Mark D. M.D., Achilles J. M.D., Ronald C. M.D., Ph.D., Robert D. M.D.,